Formulation considerations in enhancing olfactory mucosal deposition for nose-to-brain drug delivery
Drug Delivery and Translational Research · 2026-08 · 16 (8) · 2552-2577
DOI: 10.1007/s13346-026-02097-7 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Delivery and Translational Research, online erschienen am 21.03.2026. Verfasst von Anisha A DSouza und 5 weiteren Autor:innen. Beteiligte Einrichtung: Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, USA. Hauptthemen laut MEDLINE: Olfactory Mucosa, Drug Delivery Systems, Brain. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 245 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Northeastern University USA.
Abstract (Originalsprache)
Nose-to-brain (N2B) drug delivery offers a promising alternative to circumvent the blood-brain barrier and deliver therapeutic agents directly to the central nervous system. Among the intranasal pathways, targeting the olfactory mucosa is particularly attractive due to its direct anatomical and functional connection to the brain. However, effective deposition and retention of drug-loaded formulations in the olfactory region remain significant challenges, owing to complex nasal anatomy, mucociliary clearance, and limited surface area. This review critically examines the physiological and anatomical barriers to olfactory targeting and highlights recent advances in nanoparticle-based strategies designed to enhance mucosal deposition and transport. Various formulation approaches-including mucoadhesive polymers, surface-functionalized nanocarriers, and stimuli-responsive systems-are discussed alongside innovative delivery devices and administration techniques tailored for olfactory mucosal delivery. In vitro, ex vivo, and in vivo models used to evaluate these strategies are reviewed, as are safety, regulatory, and translational considerations. Finally, the review explores emerging technologies such as patient-specific delivery platforms and smart nanoparticles, offering a forward-looking perspective on the future of N2B therapeutics for neurological disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, USA.
- Department of Pharmaceutical Sciences, School of Pharmacy, Bouve College of Health Sciences, Northeastern University, Boston, MA, USA.
- Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- Department of Pharmaceutical Sciences, School of Pharmacy, Bouve College of Health Sciences, Northeastern University, Boston, MA, USA. m.amiji@northeastern.edu.
- Department of Chemical Engineering, College of Engineering, Northeastern University, Boston, MA, USA. m.amiji@northeastern.edu.
Förderung
- Northeastern University USA
Zitieren
APA
DSouza, A. A., Kahan, M., Yang, A., Padmakumar, S., Bleier, B. S., & Amiji, M. M. (2026). Formulation considerations in enhancing olfactory mucosal deposition for nose-to-brain drug delivery. Drug Delivery and Translational Research, 16(8), 2552-2577. https://doi.org/10.1007/s13346-026-02097-7
Vancouver
DSouza AA, Kahan M, Yang A, Padmakumar S, Bleier BS, Amiji MM. Formulation considerations in enhancing olfactory mucosal deposition for nose-to-brain drug delivery. Drug Delivery and Translational Research. 2026;16(8):2552-2577. doi:10.1007/s13346-026-02097-7
BibTeX
@article{DSouza2026,
author = {DSouza, Anisha A and Kahan, Maayan and Yang, Alicia and Padmakumar, Smrithi and Bleier, Benjamin S and Amiji, Mansoor M},
title = {Formulation considerations in enhancing olfactory mucosal deposition for nose-to-brain drug delivery},
journal = {Drug Delivery and Translational Research},
year = {2026},
volume = {16},
number = {8},
pages = {2552--2577},
doi = {10.1007/s13346-026-02097-7}
}
EUVIMED